Xiaoye Li

发表

Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion

Qianzhou Lv, Shuning Zhang, Qi-bing Wang, 2019, Front. Pharmacol..

Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

Zi Wang, Yao Yao, Qian-zhou Lv, 2024, Cardiovascular Innovations and Applications.

The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure

J. Ge, Qianzhou Lv, Daxin Zhou, 2021, Frontiers in Pharmacology.

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

Qianzhou Lv, Junbo Ge, Daxin Zhou, 2021, Frontiers in Pharmacology.

Dabigatran Treatment Increased Closure Device-Related Thrombosis by Platelet Activation in Patients Undergoing Percutaneous Left Atrial Appendage Closure

J. Ge, Qianzhou Lv, Daxin Zhou, 2021 .

The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis

X. Xie, Zhi-wei Feng, Y. Xue, 2017, Acta Pharmacologica Sinica.

Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study

Z. Wang, Qianzhou Lv, Xiao-ye Li, 2021, Drug design, development and therapy.

A Novel Biomarker Scoring System Alone or in Combination with the GRACE Score for the Prognostic Assessment in Non-ST-Elevation Myocardial Infarction

Z. Wang, Yan Yan, Qianzhou Lv, 2022, Clinical epidemiology.

Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure

Yao Yao, Qian-zhou Lv, Xiaoye Li, 2024, Cardiovascular therapeutics.

Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation.

Z. Wang, Chun-Lai Ma, Zhichun Gu, 2023, Cardiovascular drugs and therapy.

A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation

Z. Wang, Meixiang Yu, Qianzhou Lv, 2022, International Journal of Clinical Pharmacy.

Cilostazol Decreases Endothelin-1 Level in Patients with an Acute Coronary Syndrome: A Prospective Study

Hongyi, Z. Wang, Qianzhou Lv, 2020 .

Cilostazol increases adenosine plasma concentration in patients with acute coronary syndrome

Z. Wang, Qianzhou Lv, Jiahui Chen, 2020, Journal of clinical pharmacy and therapeutics.

Ticagrelor Compared with Clopidogrel Increased Adenosine and Cyclic Adenosine Monophosphate Plasma Concentration in Acute Coronary Syndrome Patients

Qianzhou Lv, Qi-bing Wang, Jiahui Chen, 2017, Basic & clinical pharmacology & toxicology.

Ticagrelor enhances adenosine-mediated antiplatelet effect in acute coronary syndrome patients-a prospective cohort study

Qianzhou Lv, Qi-bing Wang, Jiahui Chen, 2016 .

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

Qingfeng He, Xiao Zhu, X. Xiang, 2022, Frontiers in Pharmacology.

Cilostazol regulates the expressions of endothelin-1 and endothelial nitric oxide synthase via activation of the p38 MAPK signaling pathway in HUVECs.

Ying Xue, Zi Wang, Qian-zhou Lv, 2022, Biomedical reports.

miR-101-3p induces vascular endothelial cell dysfunction by targeting tet methylcytosine dioxygenase 2.

Ling-jun Kong, Qianzhou Lv, Xiao-ye Li, 2020, Acta biochimica et biophysica Sinica.

Plasma microRNAs reflecting cardiac and inflammatory injury in coronary artery bypass grafting surgery.

Qianzhou Lv, Jin-qiang Shen, L. Xia, 2018, The Journal of surgical research.

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension

Qianzhou Lv, Lei Zhang, Y. Long, 2017, Clinical and experimental pharmacology & physiology.

The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation

Z. Wang, Qianzhou Lv, Xiao-ye Li, 2020, British journal of clinical pharmacology.

Efficacy assessment of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention by data mining and machine‐learning decision tree approaches

Amy L. Seybert, Yankang Jing, Ziheng Hu, 2020, Journal of clinical pharmacy and therapeutics.

Influence of Aging on Outcomes of Sacubitril/Valsartan in Hypertensive Patients with Heart Failure: A Multicenter Retrospective Study

Chengchun Zuo, Dan Tian, Zhichun Gu, 2024, Anatolian journal of cardiology.

The Impact of Genetic Polymorphisms on the Anti-Hyperglycemic Effect of Dapagliflozin

Zi Wang, Qing Xu, Yao Yao, 2024, Diabetes, metabolic syndrome and obesity : targets and therapy.

Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study.

Qianzhou Lv, Xiaoyu Li, Can Chen, 2022, International journal of cardiology.

Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials

Qianzhou Lv, Can Chen, Xiaoyu Li, 2020, European Journal of Clinical Pharmacology.

Genetic Polymorphisms and Perioperative Bleeding in Off-pump Coronary Artery Bypass Grafting Surgery.

Z. Wang, Qianzhou Lv, Jin-qiang Shen, 2020, The Annals of thoracic surgery.

The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study

Qianzhou Lv, Xiao-ye Li, Zi Wang, 2023, International Journal of Clinical Pharmacy.

Does thromboelastography predict bleeding in patients treated with clopidogrel or ticagrelor in off-pump coronary artery bypass grafting?

Z. Wang, Xiao-ye Li, Ye Zou, 2022, Thrombosis research.

Clinical efficacy of clopidogrel and ticagrelor in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study

Zi Wang, Runhua Ma, Qing Xu, 2024, International journal of surgery.

Clopidogrel‐associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients

Qianzhou Lv, Qi-bing Wang, Xiao-ye Li, 2018, Basic & clinical pharmacology & toxicology.

Preoperative treatment with clopidogrel and ticagrelor on bleeding complications in off-pump coronary artery bypass grafting.

Z. Wang, Qianzhou Lv, Xiaoyu Li, 2022, Thrombosis research.

A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration

Hongyi Wu, Xiao-ye Li, Ying Xue, 2018, Case reports in vascular medicine.

Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study

Lumin Wang, Yanrong Ye, Xiaoye Li, 2024, Health science reports.

Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study

Z. Wang, Qianzhou Lv, Jia-lu Hu, 2022, Frontiers in Public Health.

Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic

Qianzhou Lv, Xiaoyu Li, Xiao-ye Li, 2020, Frontiers in Pharmacology.

Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis

Qianzhou Lv, Yan Yan, Xiao-ye Li, 2022, Frontiers in Cardiovascular Medicine.